Loading…
Based on limited metadata, this warning letter was issued to Metuchen Pharmaceuticals, LLC., a pharmaceutical company, on August 16, 2019. The specific violations and subject matter cannot be determined from the available metadata, as no detailed subject line or violation count is provided. The letter pertains to drug products under FDA oversight, though the specific issuing office is not identified. Without access to the full letter text, the precise nature of the compliance concerns remains unclear.